Gjurasić Marija
Department for Economics and Business economics, University of Dubrovnik, Croatia.
Acta Med Hist Adriat. 2010;8(1):17-58.
Nowadays, hereditary diseases are viewed through molecular mechanisms, and one of them, which keeps occurring rather frequently in medical publications, has been named after the Island of Mljet. The world first learned about mal de Meleda from a Dubrovnik physician Luka Stulli in 1826. He described it in a number of his island patients as a non-contagious hereditary skin disease, and named it mal de Meleda (a disease of Mljet). After Stulli, numerous scientists continued to investigate its aetiology and distinctive properties, introducing new scientific procedures to research the disease. The article keeps track of the way people and medicine perceived and treated mal de Meleda patients, starting from the early 19th century to the present day. It pays special attention to how the disease was perceived and described in medical literature through history. There are no reports in writing about the disease before the 19th century, but in oral tradition it was perceived as a punishment for the sins of sacrilege, sins of piracy, or even as leftovers of leprosy brought by the crusaders. We investigated if these legends have any support in preserved historical documents and to what extent they are related to real historical events and circumstances. Influenced by the booming research in microbiology, end 19th century physicians believed the disease was an isolated focus of leprosy. However, early 20th century physicians defined it as a hereditary skin disease with changes which distinguish it from other skin conditions. Genetic nature of the disease was later confirmed by molecular science. As for its geographical origin, the most recent medical research has shown that mal de Meleda is not restricted to the island of Mljet, and that it is spread worldwide, particularly in regions that, historically, were the trading routes of the Dubrovnik Republic. This implies that the mutation has spread through migration and persists only because it is not lethal and does not affect reproduction.
如今,遗传性疾病是通过分子机制来研究的,其中有一种在医学出版物中经常出现的疾病,是以姆列特岛命名的。1826年,世界首次从杜布罗夫尼克医生卢卡·斯图利那里了解到梅莱达病。他在许多岛上的病人身上将其描述为一种非传染性的遗传性皮肤病,并将其命名为梅莱达病(姆列特岛的疾病)。在斯图利之后,众多科学家继续研究其病因和独特性质,引入了新的科学方法来研究这种疾病。本文追溯了从19世纪初到现在人们和医学对梅莱达病患者的认知和治疗方式。特别关注了历史上医学文献中对该疾病的认知和描述。19世纪之前没有关于这种疾病的书面报告,但在口头传统中,它被视为对亵渎神灵之罪、海盗行为之罪的惩罚,甚至被视为十字军带来的麻风病残余。我们研究了这些传说在保存下来的历史文献中是否有依据,以及它们与真实历史事件和情况的关联程度。受微生物学蓬勃发展的影响,19世纪末的医生认为这种疾病是麻风病的一个孤立病灶。然而,20世纪初的医生将其定义为一种遗传性皮肤病,其变化使其有别于其他皮肤疾病。该疾病的遗传性质后来得到了分子科学的证实。至于其地理起源,最新的医学研究表明,梅莱达病并不局限于姆列特岛,而是遍布全球,特别是在历史上曾是杜布罗夫尼克共和国贸易路线的地区。这意味着该突变通过迁移传播,并且仅因为它不致命且不影响繁殖而持续存在。